Real-world efficacy and safety of nivolumab and ipilimumab in metastatic renal cell carcinoma: a Polish multicenter study
This study confirms the real-world efficacy and safety of NIVO+IPI in mRCC, demonstrating outcomes comparable to clinical trials.
Authors
- Renata Pacholczak‐Madej (ORCID: https://orcid.org/0000-0002-6535-4841)
- Angelika Gawlik-Urban (ORCID: https://orcid.org/0000-0003-1396-1196)
- Paweł Blecharz (ORCID: https://orcid.org/0000-0001-5310-0054)
- Artur Drobniak
- Mirosława Püsküllüoğlu (ORCID: https://orcid.org/0000-0002-2647-9625)
- Aleksandra Grela-Wojewoda (ORCID: https://orcid.org/0000-0002-6727-8926)
- Jerzy Walocha (ORCID: https://orcid.org/0000-0001-8587-2315)
- Jacek Calik (ORCID: https://orcid.org/0000-0002-4492-8551)
- Agnieszka Roman
- Jolanta Dobrzańska
- Łukasz Stokłosa
- Anna Bidas
- Daria Tusień-Małecka
- Marek Szwiec
- Natalia Versuti Viegas
Institutions
- College of the Holy Cross (US)
- Jagiellonian University (PL)
- Akademia Tarnowska (PL)
- National Institute of Oncology (HU)
- Grochowski Hospital (PL)
- York District Hospital (US)
- University of Zielona Góra (PL)
Publication Details
- Journal
- Future Oncology
- Published
- 2025-05-20
- DOI
- https://doi.org/10.1080/14796694.2025.2508138
- Citations
- 1
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52